ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Thursday reported a loss of $61.9 million in its third quarter.
On a per-share basis, the Rockville, Maryland-based company said it had a loss of $1.20.
The results beat Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.38 per share.
The biotechnology company posted revenue of $29.7 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $24 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX
/Cybersecurity%20by%20AIBooth%20via%20Shutterstock.jpg)